Newsbenzinga
ResMed Analyst Backs Portfolio Reset
· Published
Article summary
ResMed is selling MatrixCare for $490 million to sharpen its sleep health focus as analysts weigh near-term EPS dilution against long-term growth.
An excerpt from the original article.
Comments —
Loading comments…